Urothelial Carcinoma of the Ureter
📧 Sign up to get email alerts when something new happens for Urothelial Carcinoma of the Ureter.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy [Phase 3]
Phase 3 trial update evaluating the optimal duration of immune checkpoint therapy for locally advanced and metastatic urothelial carcinoma; …
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL) [Phase 2]
SWOG's Phase 2 trial evaluating adding avelumab to gemcitabine and carboplatin before surgery in cisplatin-ineligible muscle-invasive urinar…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer [Phase 1, Phase 2]
This update reports results from a Phase 1/2 trial evaluating ALT-801 in combination with cisplatin and gemcitabine in patients with muscle-…
-
CLINICAL_TRIALS trial_result · 2021-12-17Clinical Trial Update: A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer [Phase 2]
Phase 2 study of enfortumab vedotin in locally advanced or metastatic urothelial cancer has been completed and results have been posted. The…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium [Phase 2]
This updates the completion of a Phase 2 trial of sunitinib in patients with progressive metastatic urothelial cancer (transitional cell car…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-09-03Clinical Trial Update: Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract [Phase 2]
Phase 2 trial evaluating sorafenib in advanced or metastatic urothelial cancers of the urinary tract (including bladder, renal pelvis, and u…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer [Phase 2]
Phase 2 trial update evaluating gefitinib in combination chemotherapy for locally advanced or metastatic bladder cancer (urothelial carcinom…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Arsenic Trioxide in Treating Patients With Urothelial Cancer [Phase 2]
A Phase 2 clinical trial evaluating arsenic trioxide in patients with recurrent urothelial cancers (including bladder, renal pelvis, ureter,…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium [Phase 2]
A Phase 2 SWOG trial evaluating combination chemotherapy followed by observation or surgery in patients with stage II–III urothelial cancer …
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium [Phase 2]
Phase 2 trial evaluating trastuzumab for previously treated, locally advanced or metastatic urothelial cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Pazopanib in Treating Patients With Metastatic Urothelial Cancer [Phase 2]
A Phase 2 trial of pazopanib in metastatic urothelial cancer has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2011-04-04Clinical Trial Update: Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium [Phase 2]
This Phase 2 trial evaluated Sorafenib in regional or metastatic urothelial cancer and was terminated with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-01-12Clinical Trial Update: A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer [Phase 2]
This document reports the completion and results posting of a Phase II study of AZD4877, an anti-mitotic agent, in advanced bladder cancer a…
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium [Phase 2]
Phase 2 trial evaluating vinflunine in locally advanced or metastatic urothelial carcinoma of the urothelium (bladder cancer); the study has…